On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
On Apr. 29, 2016, GlaxoSmithKline Biologicals in Research Triangle Park, North Carolina, received U.S. Food and Drug Administration…
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Feb. 12, 2009, the Vaccine Court ruled that MMR vaccine, when administered with thimerosal-containing vaccines, does not…
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration had licensed Pentacel, Diphtheria and…
On Jun. 20, 2008, the FDA approved Pentacel (Sanofi Pasteur), a new combination DTaP-IPV-Hib vaccine for use in…
On Dec. 12, 2007, Merck voluntarily recalled 1.2 million doses of Haemophilus influenzae type b (Hib) vaccines due…
On Jan. 15. 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
On Aug. 26, 1998, the Children’s Vaccine Program was established at WHO’s Program for Appropriate Technology in Health…
On Oct. 2, 1996, the Food and Drug Administration (FDA) licensed a combined Hib conjugate and hepatitis B…
On Jan. 11, 1991, recommendations of Immunization Practices Advisory Committee (ACIP) for routine Hib vaccination for infants beginning…
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
On Oct. 4, 1990, the FDA approved the use of Haemophilus b Conjugate Vaccine (Diphtheria CRM 197 Protein…
On Apr. 13, 1990, the Immunization Practices Advisory Committee (ACIP) recommendations for use of any of the three…
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…
On Jan. 22, 1988, the Immunization Practices Advisory Committee (ACIP) recommended the Hib conjugate vaccine be provided to…
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
On Apr. 12, 1985, the Haemophilus influenzae type b (Hib) polysaccharide vaccines (b-CAPSA 1 by Praxis Biologics, Hib-VAX…
On Jun. 12, 1966, the Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with…
In 1939, Margaret Pittman showed that sulfapyradine was effective against nontype-specific Haemophilus influenzae. Pittman discovered that there are…